Schonfeld Strategic Advisors LLC Shattuck Labs, Inc. Transaction History

Schonfeld Strategic Advisors LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$2.6 - $5.52 $780 - $1,655	-300 Reduced 2.7%	10,800 $29,000
Q2 2022 Aug 15, 2022	SELL	$2.7 - $4.59 $21,060 - $35,802	-7,800 Reduced 41.27%	11,100 $45,000
Q1 2022 May 16, 2022	BUY	$4.22 - $8.89 $79,758 - $168,021	18,900 New	18,900 $80,000

28.8M

300

1.2K

Ticker STTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,382,000
Market Cap $46.6M
Description
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.